Seroatlas · Human Serome Atlas

HPGDS

Hematopoietic prostaglandin D synthase

Also known as: GSTS, GSTS1, GSTS1-1, H-PGDS, HPGDS_HUMAN, PGD2, PGDS

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O60760
Gene
HPGDS
Ensembl
ENSG00000163106
Chromosome
4
Canonical length
199 aa
Protein class
Enzymes, Metabolic proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Vesicles,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

Prostaglandin-D synthase is a sigma class glutathione-S-transferase family member. The enzyme catalyzes the conversion of PGH2 to PGD2 and plays a role in the production of prostanoids in the immune system and mast cells. The presence of this enzyme can be used to identify the differentiation stage of human megakaryocytes. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

199 residues, UniProt reviewed canonical sequence.

>O60760|HPGDS
     1  MPNYKLTYFN MRGRAEIIRY IFAYLDIQYE DHRIEQADWP EIKSTLPFGK IPILEVDGLT
    61  LHQSLAIARY LTKNTDLAGN TEMEQCHVDA IVDTLDDFMS CFPWAEKKQD VKEQMFNELL
   121  TYNAPHLMQD LDTYLGGREW LIGNSVTWAD FYWEICSTTL LVFKPDLLDN HPRLVTLRKK
   181  VQAIPAVANW IKRRPQTKL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against HPGDS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
18 nTPM

Expression across tissuesHPA

Tissue

  • placenta: 18 nTPM
  • lung: 8.9 nTPM
  • gallbladder: 6.4 nTPM
  • duodenum: 5.5 nTPM
  • small intestine: 5.2 nTPM
  • rectum: 5 nTPM

Single-cell type

  • mast cells: 1,807 nCPM
  • hofbauer cells: 1,753 nCPM
  • tuft cells: 1,176 nCPM
  • microglia: 112 nCPM
  • macrophages: 63 nCPM
  • megakaryocyte progenitors: 45 nCPM

Immune cell

  • basophil: 18 nTPM
  • T-reg: 0.6 nTPM
  • eosinophil: 0.3 nTPM
  • memory CD4 T-cell: 0.3 nTPM
  • classical monocyte: 0.1 nTPM
  • intermediate monocyte: 0.1 nTPM

Brain region

  • white matter: 4.1 nTPM
  • thalamus: 3.2 nTPM
  • medulla oblongata: 2.6 nTPM
  • pons: 2.4 nTPM
  • spinal cord: 2.2 nTPM
  • cerebellum: 1.6 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about HPGDS.

Disease | AutoantibodyPubMed

Conditions in which antibodies against HPGDS are reported. Each links to that disease's full target list.

ReferencesPubMed · IEDB

Publications for HPGDS from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

11 publications

Show 6 more

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.63
gnomAD pLI
0
gnomAD missense Z
-1.03
DepMap mean gene effect
-0.09
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads HPGDS as an antibody target. Whether an autoantibody or antibody against HPGDS could matter depends on whether native HPGDS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

HPGDS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label HPGDS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/HPGDS. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...